Clinical and translational gastroenterology

Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

UCSF- Core Immunology Lab

Mission

Provide state-of-the-art immunology assay services and instrumentation in support of translational research.

Education

To train and mentor staff, students, fellows, and junior investigators in immunology research, stimulate inclusion of immunology research in new studies, and help community members understand and interpret findings.

Research

To develop, optimize, validate, and apply innovative, specialized flow cytometry and immunoassays.

UCSF- Core Immunology Lab

Search form

You are here

Clinical and translational gastroenterology

Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

Mission

Education

Research